Treatment of severe steroid refractory acute graft versus host disease with Infliximab, a chimeric human/mouse anti-TNF-alpha antibody

被引：0
|
作者：
Kobbe, G
Schneider, P
Fenk, R
Rohr, U
Neumann, F
Aivado, M
Rong, A
Hünerlitürkoglu, A
Haas, R
机构：
来源：
BONE MARROW TRANSPLANTATION | 2001年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S180 / S180
页数：1
相关论文
共 50 条
  • [21] Infliximab for the treatment of steroid refractory graft-versus-host disease in allogeneic transplant recipients.
    Hicks, K
    Ippoliti, C
    Donato, M
    Champlin, R
    Khouri, I
    Andersson, B
    Anderlini, P
    Gajewski, J
    Giralt, S
    BLOOD, 1999, 94 (10) : 155A - 155A
  • [22] DACLIZUMAB AND INFLIXIMAB FOR TREATMENT OF STEROID RESISTANT ACUTE GRAFT VERSUS HOST DISEASE (aGVHD) IN PEDIATRICS
    Snyder, R. L.
    Daum, C.
    Klinger, E.
    Neudorf, S.
    Simpson, L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 140 - 140
  • [23] Alemtuzumab for Severe Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease
    Meunier, Mathieu
    Bulabois, Claude Eric
    Thiebaut-Bertrand, Anne
    Itzykson, Raphael
    Carre, Martin
    Carras, Sylvain
    Garban, Frederic
    Cahn, Jean Yves
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (09) : 1451 - 1454
  • [24] Alemtuzumab in the treatment of steroid refractory acute Graft-versus-Host Disease.
    Gomez-Almaguer, David
    Ruiz-Arguelles, Guillermo
    Gonzalez-Llano, Oscar
    Cantu, Olga G.
    Gutierrez, Cesar H.
    Jaime-Perez, Jose Carlos
    Tarin-Arzaga, Luz
    Giralt, Sergio
    BLOOD, 2006, 108 (11) : 415B - 416B
  • [25] Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
    Hoda, D.
    Pidala, J.
    Salgado-Vila, N.
    Kim, J.
    Perkins, J.
    Bookout, R.
    Field, T.
    Perez, L.
    Ayala, E.
    Ochoa-Bayona, J. L.
    Raychaudhuri, J.
    Alsina, M.
    Greene, J.
    Janssen, W.
    Fernandez, H. F.
    Anasetti, C.
    Kharfan-Dabaja, M. A.
    BONE MARROW TRANSPLANTATION, 2010, 45 (08) : 1347 - 1351
  • [26] Treatment and Nursing for Steroid-Refractory Acute Graft-Versus-Host Disease
    Cazeau, Naomi
    Rodriguez, Stephany L.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2023, 27 (04) : 397 - 403
  • [27] Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease
    Gomez-Almaguer, David
    Ruiz-Arguelles, Guillenmo J.
    Tarin-Arzaga, Luz del Carmen
    Gonzalez-Llano, Oscar
    Gutierrez-Aguirre, Homero
    Cantu-Rodriguez, Olga
    Jaime-Perez, Jose
    Carrasco-Yalan, Antonio
    Giralt, Sergio
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (01) : 10 - 15
  • [28] Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab
    Willenbacher, W
    Basara, N
    Blau, IW
    Fauser, AA
    Kiehl, MG
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (03) : 820 - 823
  • [29] Tocilizumab for the Treatment of Steroid Refractory Acute Graft Versus Host Disease: A Pediatric Experience
    Bhatt, Sima
    Schulz, Ginny
    Towerman, Alison
    Hente, Monica
    Shenoy, Shalini
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S389 - S390
  • [30] Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
    D Hoda
    J Pidala
    N Salgado-Vila
    J Kim
    J Perkins
    R Bookout
    T Field
    L Perez
    E Ayala
    J L Ochoa-Bayona
    J Raychaudhuri
    M Alsina
    J Greene
    W Janssen
    H F Fernandez
    C Anasetti
    M A Kharfan-Dabaja
    Bone Marrow Transplantation, 2010, 45 : 1347 - 1351
12345